PHAR: Pharming Group N.V. Company Short-Term Debt
Pharming Group N.V. (PHAR) demonstrates absolute independence from economic cycles and external shocks. The quote characteristics for the separate_debt_short metric are at 0.00. The company relies on the rapid development of its rare disease therapy pipeline, expanding its market reach. High margins are driven by the easy replication of existing formulas, making the production model extremely efficient for global scaling.
Metric breakdowns and analytics for Pharming Corp (PHAR)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Pharming Group N.V.|PHAR - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Pharming Group N.V.|PHAR - Company Total Debt|Debt to Book Capitalization Ratio Pharming Group N.V.|PHAR - Company Long-Term Liabilities|Company Current Liabilities Pharming Group|Quick Liquidity pharming.com
- net income and valuation multiples indicators:
Initial company analysis:PHAR - Pharming Group
Pharming Group N.V. specializes in developing drugs for the treatment of rare immune pathologies. An analysis of the current volume of short-term loans demonstrates the company's obligations with maturities of up to one year. This metric measures the efficiency of operational liquidity management and the management's ability to service debt using current cash flows. For the biopharmaceutical sector, this is a critical marker of financial stability when scaling gene therapy. The stability of this indicator confirms the fundamental reliability of the business.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO - Company Short-Term Debt|Current Liabilities IMNM|GOSS: Company Short-Term Debts|kalvista.com - Company Short-Term Loans and Borrowings|SEPN (Septerna) - Company Short-Term Debts|Company Short-Term Debts Pieris Pharma|Company Short-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt AnaptysBio, Inc. ANAB|ATXS - Company Current Liabilities|enGene - Company Short-Term Debts|Short-Term Debt Volume rapt.com RAPT|aerovatetx.com (JBIO) - Company Short-Term Debt|Company Short-Term Indebtedness ACRS|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|TLSA - Short-Term Indebtedness|Company Current Liabilities CABA (Cabaletta Bio)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Short-Term Indebtedness Avalo Therapeutics Inc|ELDN - Company Short-Term Debt|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|Climb Bio (CLYM) - Company Short-Term Debt|Short-Term Debt zurabio.com (ZURA)|Company Current Liabilities ATYR|Company Short-Term Debts Adagene Corp|Company Short-Term Debt ImageneBio Inc (IMA)|STTK: Current Liabilities|Equillium - Company Current Liabilities|Company Short-Term Loans and Borrowings CNTB|IMUX - Company Short-Term Debt|ATRA (Atara Biotherapeutics) - Company Short-Term Indebtedness|IFRX (inflarx.de) - Company Current Liabilities|XFOR - Short-Term Debt Volume|Company Current Liabilities ACET|Company Short-Term Debt CELU|Company Current Liabilities INMB (INmune Bio Corp)|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debt Kezar Life Sciences KZR|SABS (sabbiotherapeutics.com) - Current Liabilities|Akari Therapeutics Plc - Company Short-Term Debts|Company Short-Term Loans and Borrowings ENLV (Enlivex Therapeutics)|QTTB: Company Short-Term Debts|GeoVax Corp (GOVX) - Company Short-Term Debts|Company Short-Term Debt Edesa Biotech, Inc.|IBIO: Company Short-Term Loans and Borrowings|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB: Current Liabilities|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)